Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified
Intelligent Bio Solutions Inc. announced the successful completion of penetration testing with no major vulnerabilities identified as part of its FDA 510(k) submission process. The company also implemented enhanced security upgrades to its drug testing technology, aimed at safeguarding data and ensuring regulatory compliance. Clearance from the FDA…